FK506-binding protein 51 (FKBP51), a pro-cancer factor associated with melanoma cells related to drug resistance and epigenetic changes, has been shown to increase the expression of TRAIL-R2 when silenced, thereby enhancing melanoma cell sensitivity to TRAIL-induced apoptosis in vitro [30]. This evidence concerns the gene TNFSF10 and melanoma.